Granot Zvi, Geiss-Friedlander Ruth, Melamed-Book Naomi, Eimerl Sarah, Timberg Rina, Weiss Aryeh M, Hales Karen H, Hales Dale B, Stocco Douglas M, Orly Joseph
Department of Biological Chemistry, The Alexander Silberman Institute of Life Sciences, The Hebrew University of Jerusalem, Jerusalem 91904, Israel.
Mol Endocrinol. 2003 Dec;17(12):2461-76. doi: 10.1210/me.2003-0074. Epub 2003 Sep 4.
Steroidogenic acute regulatory protein (StAR) is a nuclear encoded mitochondrial protein that enhances steroid synthesis by facilitating the transfer of cholesterol to the inner membranes of mitochondria in hormonally regulated steroidogenic cells. It is currently assumed that StAR activity commences before or during StAR import into the mitochondrial matrix. The present study was designed to demonstrate that, once imported and becoming physiologically irrelevant, exhaustive accumulation of StAR must be limited by a rapid degradation of the protein to prevent potential damage to the organelles. The use of uncouplers and manipulation of the interior mitochondrial pH in hormone-induced ovarian granulosa cells and StAR-expressing COS cells suggests that StAR degradation is biphasic and involves two classes of proteases. During phase I, which normally lasts for the first approximately 2 h following import, StAR is rapidly degraded by a protease, or proteases, that can be arrested by a nonclassical action of proteasome inhibitors such as MG132. StAR molecules that evade phase I are subjected to a second class of protease(s), which is slower and MG132 resistant. A third proteolytic entity was revealed in studies with C-28 StAR, a loss-of-function mutant of StAR. Upon initiation of its import, C-28 StAR dissipates the inner membrane potential and causes swelling of the mitochondria. Degradation of C-28 StAR, probably by an intermembrane space protease, is extremely rapid and MG132 insensitive. Collectively, this study defines StAR as the first naturally occurring mitochondrial protein that can serve as a substrate to probe multiple proteolytic activities in mammalian mitochondria.
类固醇生成急性调节蛋白(StAR)是一种由细胞核编码的线粒体蛋白,它通过促进胆固醇向激素调节的类固醇生成细胞中的线粒体内膜转移来增强类固醇合成。目前认为,StAR活性在其导入线粒体基质之前或期间就已开始。本研究旨在证明,一旦导入并变得生理上无关紧要,StAR的过度积累必须通过蛋白质的快速降解来限制,以防止对细胞器造成潜在损害。在激素诱导的卵巢颗粒细胞和表达StAR的COS细胞中使用解偶联剂和操纵线粒体内pH值表明,StAR降解是双相的,涉及两类蛋白酶。在第一阶段,通常在导入后的最初约2小时内,StAR会被一种蛋白酶或多种蛋白酶迅速降解,这种降解可被蛋白酶体抑制剂如MG132的非经典作用所阻断。逃避第一阶段的StAR分子会受到第二类蛋白酶的作用,其降解速度较慢且对MG132有抗性。在对StAR的功能丧失突变体C-28 StAR的研究中发现了第三种蛋白水解实体。在其导入开始时,C-28 StAR会消散内膜电位并导致线粒体肿胀。C-28 StAR的降解可能由膜间隙蛋白酶介导,速度极快且对MG132不敏感。总的来说,本研究将StAR定义为第一种天然存在的线粒体蛋白,它可作为一种底物来探测哺乳动物线粒体中的多种蛋白水解活性。